8-K: Dentsply Sirona Reports Mixed Q3 Results, Revises Full-Year Outlook

Dentsply Sirona's third quarter results show a slight increase in net sales but a significant net loss due to goodwill impairment, leading to a revised full-year outlook.

Summary

• Dentsply Sirona reported a 0.5% increase in net sales to $951 million for the third quarter of 2024, with organic sales up by 1.3%.
• The company experienced a net loss of $494 million, or $2.46 per share, primarily due to a $495 million non-cash goodwill impairment charge.
• Adjusted earnings per diluted share were $0.50, slightly up from $0.49 in the same quarter last year.
• The company has revised its full-year organic sales outlook to a decline of 2.5% to 3.5%, down from the previous guidance of a 1% decline to flat growth.
• Adjusted EPS for the full year is now expected to be between $1.82 and $1.86, down from the previous range of $1.96 to $2.02.
• The revised outlook is due to market pressures in the U.S. equipment sector, legislative changes affecting the direct-to-consumer aligner business, and the suspension of Byte aligner sales.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to a significant net loss, a large goodwill impairment, and a downward revision of the full-year guidance. While there are some positive aspects, such as increased operating cash flow, the overall tone is pessimistic.

Positives

• Net sales saw a slight increase of 0.5% compared to the same quarter last year.
• Organic sales grew by 1.3% in the third quarter.
• Adjusted earnings per share increased slightly to $0.50 from $0.49.
• Operating cash flow improved to $141 million from $134 million year-over-year.
• The company returned $345 million to shareholders through dividends and share repurchases in the first nine months of 2024.

Negatives

• The company reported a substantial net loss of $494 million, primarily due to a $495 million goodwill impairment.
• The full-year organic sales outlook has been revised downwards to a decline of 2.5% to 3.5%.
• The full-year adjusted EPS outlook has been lowered to $1.82 to $1.86.
• The Orthodontic and Implant Solutions segment experienced a 4.6% decline in net sales and a 3.9% decline in organic sales.
• The company is facing market pressures in the U.S. equipment sector and challenges with its Byte aligner business.

Risks

• The company faces sustained macroeconomic pressures and legislative trends impacting the Byte business.
• There is weakened demand and competitive pressures in the implants market.
• Lower expected volumes of lab materials are impacting the Orthodontic and Implant Solutions segment.
• The company is experiencing market pressures impacting equipment in the U.S.
• The evolving landscape with Byte is negatively affecting the company's outlook.
• The company's revised outlook does not include potential adjustments or impacts of additional Byte remediation measures or decisions.

Future Outlook

The company has revised its full-year outlook, expecting a decline in organic sales between 2.5% and 3.5% and adjusted EPS between $1.82 and $1.86. This revision is due to market pressures, legislative changes, and the suspension of Byte aligner sales. The outlook does not include potential adjustments or impacts of additional Byte remediation measures or decisions.

Management Comments

• Third quarter organic growth was driven by favorable timing in Essential Dental Solutions and higher sales in CAD/CAM.
• Due to ongoing market pressures impacting equipment in the U.S., as well as the evolving landscape with Byte, we are lowering our full year organic sales outlook.
• We continue to transform Dentsply Sirona and pivot quickly where needed.
• While we have more work to do, we now have multiple initiatives contributing positively to profitability and strengthening our Company's foundation for the long term.

Industry Context

The dental industry is facing challenges, particularly in the direct-to-consumer aligner market, as evidenced by the issues with Byte. Dentsply Sirona's revised outlook reflects these broader industry pressures, especially in the U.S. equipment sector. The company's focus on innovation, such as the new Primescan 2 scanner, is an attempt to maintain competitiveness in a changing market.

Comparison to Industry Standards

• Dentsply Sirona's Q3 2024 results show a mixed performance compared to industry peers.
• While the 0.5% increase in net sales is modest, the significant net loss due to goodwill impairment is concerning.
• Companies like Align Technology, which also operates in the orthodontic space, have faced similar challenges in the direct-to-consumer market, but Dentsply Sirona's impairment charge is notably large.
• The revised full-year outlook is a significant downgrade, indicating that the company is facing more headwinds than initially anticipated.
• Other dental equipment manufacturers, such as Straumann, have shown more resilience in their recent results, suggesting that Dentsply Sirona's challenges may be more company-specific than industry-wide.

Management Changes

Stakeholder Impact

• Shareholders will be negatively impacted by the net loss and revised outlook.
• Employees may be affected by the restructuring and transformation initiatives.
• Customers may experience changes in product availability due to the suspension of Byte aligner sales.
• Suppliers may be impacted by changes in demand and production volumes.
• Creditors may be concerned about the company's financial performance and revised outlook.

Next Steps

• The company will host an investor conference call and live webcast on November 7, 2024, at 8:30 am ET.
• The company will continue to transform and pivot quickly where needed.
• The company will continue to implement initiatives to improve profitability and strengthen its foundation.

Key Dates

Keywords

Dentsply Sirona, Dental Products, Financial Results, Q3 2024, Organic Sales, Adjusted EPS, Goodwill Impairment, Byte Aligners, Dental Technology, Medical Devices